Analysts bullish on Chainlink, Hedera, and Pomerdoge

The crypto market has been volatile in the past few weeks. While many coins struggle to recover, analysts hold high hopes for some projects. Based on their analysis of Chainlink (LINK), Hedera (HBAR), and Pomerdoge (POMD), they expect prices to grow by the end of the year.

Chainlink activity rising

Investors are bullish on Chainlink’s prospects, citing the growing trading volume, up 20% on the last day. 

With rising volumes, traders expect LINK prices to break above the $6.21 resistance level. 

If this happens, the token may surge to above $8 by December.

Hedera showing signs of growth

Like Chainlink, traders are also tracking Hedera. 

Although HBAR prices fell 16% in the last month, the coin is up 2% on the previous day, and traders expect more growth in the coming days. 

Analysts expect HBAR prices to break above $0.060 as bulls push for $0.062 by the end of December.

Pomerdoge finds adoption

Analysts bullish on Chainlink, Hedera, and Pomerdoge - 1

Pomerdoge aims to make inroads in crypto and reshape the play-to-earn (P2E) scene. The platform allows gamers to play and earn from their activity. 

Considering the project’s prospects, Hedera and Chainlink investors are exploring and examining the ongoing POMD presale.

Presale investors are granted exclusive access to the 7,777 high-value non-fungible tokens (NFTs) they can trade.

Also, a share of revenue generated from Pomerdoge’s gaming platform (Pomergame) will be distributed to presale investors. Users can also trade their in-game assets in Pomerplace, the Pomerdoge marketplace. 

Pomerdoge will also lock their liquidity for life to prevent a rug pull. Moreover, the project’s code has been audited by SolidProof and Cyberscope. 

In the ongoing presale, POMD is available for $0.0165, and experts expect the token to grow consistently in the coming months.

Find out more about the Pomerdoge (POMD) presale today:


Telegram community:  

Disclosure: This content is provided by a third party. does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.

Follow Us on Google News

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker